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Abstract
This retrospective study evaluated perioperative outcomes of  open partial nephrectomy (OPN), laparoscopic partial ne-
phrectomy (LPN), and robot-assisted partial nephrectomy (RAPN) and identified predictive factors of  Trifecta achievement 
for renal tumors that underwent partial nephrectomy (PN) in a single institutional cohort. The study involved patients who 
underwent PN from January 2011 to July 2018. Trifecta was defined as absence of  perioperative complications, no positive 
surgical margins, and ischemia time <30 min. Fifty-five PN procedures were reviewed: 28 OPN, 14 LPN, and 13 RAPN. 
OPN, LPN and RAPN had similar median tumor size (5.75, 5.25, and 5 cm), nephrometry score (7, 6, and 6), and preoper-
ative creatinine (1.09, 1.1, and 1.1 mg/dl, respectively). Blood loss was higher for OPN (550 ml) than for LPN (400 ml) and 
RAPN (300 ml), P = 0.042. Drain was removed after 6 days in OPN which was higher than LPN and RAPN (4.5 and 4 days, 
respectively), P = 0.008. OPN, LPN, and RAPN had similar median operative time (190, 180, and 180 min, respectively), 
P = 0.438. Median postoperative stay for OPN, LPN, and RAPN was 5, 6.5, and 10 days, respectively. Trifecta outcomes of 
73.1%, 64.3%, and 61.53% were achieved in OPN, LPN, and RAPN, respectively, P = 0.730. It was concluded that Trifecta 
outcomes had no significant difference among OPN, LPN, and RAPN. LPN can produce as good results as RAPN. Keeping 
in mind the cost-effectiveness, LPN holds an important position in developing countries where expenditure by patient is a 
major factor.
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Introduction
Currently, partial nephrectomy (PN) is the preferred modal-
ity of treatment for small renal masses. The American Uro-
logical Association Guideline recommends nephron-sparing 
surgery for T1 renal mass, as there is increased risk of chronic 
kidney disease (CKD) associated with radical nephrectomy 
(RN) (1). Furthermore, European Association of Urology 
(EAU) guidelines have also recommended PN for T1b tumors 
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as it preserves well normal renal parenchyma as well as pro-
vides oncological efficacy (2). Open PN (OPN) has been 
considered as the “gold standard” approach for many years. 
With advancements in laparoscopic techniques, equipment, 
and surgeons’ skills, laparoscopy has been adopted world-
wide, thereby offering comparable oncological outcomes, less 
morbidity, and shortened convalescence compared to open 
approach (2–7). But laparoscopic PN is a technically chal-
lenging procedure which is presently limited to few surgeons 
in select centers in developing countries. Since the last de-
cade, with widespread diffusion of robotic technology, there 
is increased adoption of robotic-assisted partial nephrectomy 
in providing a minimally invasive option for patients with 
clinical T1a lesions.
The outcomes of PN have been defined in terms of “Tri-
fecta” which means no complications, negative surgical mar-
gins, and minimal renal functional decrease (8). The objective 
of the present study is to determine the complications and 
perioperative outcome measures associated with different 
techniques of PN for renal tumors.
Materials and Methods
After taking institutional ethics approval, the records of pa-
tients who underwent OPN, LPN, and RAPN for renal masses 
at the Jawaharlal Institute of Postgraduate Medical Education 
and Research (JIPMER), Puducherry, between January 2011 
and July 2018 were reviewed. Patients having incomplete data, 
solitary kidneys, clinical evidence of metastatic renal cancer, 
previous renal carcinoma, or renal surgery were excluded.
For each RAPN, two OPNs were matched in terms of 
 patient age (within 10 years) and RENAL nephrometry score 
(within 2) from a pool of all PN cases performed between 
January 2011 and July 2018. RAPN and LPN cases were not 
directly matched because they were performed by the same 
two surgeons with equal number of cases and the same mass 
characteristics were used to select patients for both of these 
treatment modalities. No significant difference was seen in 
the mass size or nephrometry score between the two groups. 
The preoperative characteristics of these two groups were 
compared to ensure that they were similar.
The baseline demographic, disease, and treatment-related 
parameters were extracted from the hospital records in a 
de-identified manner. These data included age, sex, size, and 
location of tumor, mode of surgery (OPN/LPN/RAPN), 
indication for surgery, tumor pathology, serum creatinine 
preoperatively and at discharge. Perioperative data included 
duration of surgery, blood loss, number of blood transfu-
sions, warm ischemia time (WIT), day of drain removal, hos-
pital stay, need for intraoperative cooling, and postoperative 
complications. Nephrometry score was determined using the 
formula by Kutikov and Uzzo (9). The margin status of the 
resected tumor was recorded from the final histopathological 
examination report. The preoperative characteristics of the 
groups were compared to ensure that they were similar. The 
Trifecta achieved was defined as negative surgical margins, 
no serious perioperative complications (Clavien Dindo >2), 
and WIT<30 min.
The data were analyzed using SPSS, version 19. Comparison 
of the medians between groups was made using the Kruskal–
Wallis test. The nominal variables were compared using chi-
square test or Fisher’s exact tests to determine significance.
Results
Among the 53 patients who underwent PN, 26 had OPN, 14 
had LPN, and 13 had RAPN (Table 1). The patient character-
istics in OPN, LPN, and RAPN were similar in terms of me-
dian tumor size (5.75, 5.25, and 5 cm, respectively, P = 0.219), 
age (49 years, Range: 29–80; 48.5 years, Range:19–58; and 
42 years, Range: 29–72, P = 0.338), median preoperative creat-
inine values (1.09, 1.1, and 1.1 mg/dl, respectively), and tumor 
complexities using RENAL nephrometry score as a measure 
(7, 6, and 7, respectively). Median blood loss was higher for 
OPN (500 ml, Range: 100–2,000) than LPN (400 ml, Range: 
150–750) and RAPN (300 ml, Range: 100–800), P = 0.042. 
Median postoperative hospital stay was lower for RAPN 
(5  days, Range: 4–24) than OPN (10 days, Range: 6–22) 
and LPN (6.5 days, Range: 5–10), P = 0.154. Postoperative 
drain was removed after 6, 4.5, and 4 days in OPN, LPN, and 
RAPN, respectively, P = 0.008. OPN, LPN, and RAPN were 
similar in median operative time (190, 180, and 180 min, re-
spectively, P = 0.438) and median WIT (23, 24.5, and 27 min, 
respectively, P = 0.923). Cold ischemia was used in 12 (46.1%) 
OPN while all LPN and RAPN underwent warm ischemia.
The postoperative complications (Clavien Dindo >2) were 
two in each group (Table 2). It comprised four urinoma (one 
in OPN, two in LPN, and one in RAPN) which was drained 
by putting a pigtail and Foley’s catheter. One patient of 
RAPN developed pseudoaneurysm and underwent angioem-
bolisation. One patient of OPN had to be managed in the 
intensive care unit due to sepsis. Total number of patients re-
quiring blood transfusions in OPN, LPN, and RAPN were 6 
(23%), 1 (7%), and 1(7%), respectively, P = 0.281. OPN, LPN, 
and RAPN had one case each with positive surgical margins 
on histopathological report. Malignancies were identified in 
20 (76.9%) OPN, 10 (71.4%) LPN, and 11 (84.6%) RAPN 
(Table 1); the majority were clear-cell carcinoma. One patient 
of LPN postoperative was identified as renal cell carcinoma 
with Fuhrman grade 3 with renal sinus involvement and 
underwent radical nephrectomy later. Trifecta was achieved 
in 19 (73.1%) in OPN, 9 (64.3%) in LPN, and 8 (61.5%) in 
RAPN, P = 0.730.
Discussion
In our study, 53 PN (26 OPN, 14 LPN, and 13 OPN) were 
reviewed with similar tumor size, nephrometry score, age, and 
gender. OPN had significantly higher blood loss than LPN, 
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Table 1: Patient and tumor characteristic
Variables OPN (n = 26) LPN(n = 14) RAPN (n = 13) P
Median age, years (Range) 49 (29–80) 48.5 (19–58) 42 (29–72) 0.338
Males (%) 16 (61.5) 8 (57.1) 8 (61.5) 0.959
Females (%) 10 (38.5) 6 (42.9) 5 (38.5) 0.959
Median size, cm (Range) 5.75 (3–16) 5.25 (1.6–15) 5 (2–11) 0.219
Median preop Cra, mg/dl (Range) 1.09 (0.8–4.7) 1.1 (0.8–1.8) 1.1 (0.9–5.5) 0.935
Median preop eGFRb, ml/min/1.73 m² (Range) 64.06 (13.8–111.6) 62.21 (43–98.2) 67.06 (11.9–100.2) 0.954
Median postop Cra, mg/dl (Range) 1.11 (0.7–9.1) 1.0 (0.8–2.1) 1.1 (0.73–9.09) 0.421
Median postop eGFRb, ml/min/1.73 m² (Range) 59.20 (6.5–114.9) 62.89 (36–116.3) 65.62 (6.7–93.9) 0.401
Hypertension (%) 7 (26.9) 3 (21.4) 3 (23) 0.482
Diabetes mellitus (%) 6 (23) 3 (21.4) 2 (15.3) 0.324
Median RENAL score (Range) 7 (4–11) 6 (4–10) 7 (4–10) 0.177
Malignant tumor (%) 20 (76.9) 10 (71.4) 11 (84.6)
0.714
Clear-cell RCC (%) 18 (90) 8 (80) 9 (81.8)
Papillary cell RCCc (%) 2 (10) 1 (10) 2 (18.2)
Multilocular cystic carcinoma (%) - 1 (10) -
Benign tumors (%) 6 (23) 4 (28.5) 2 (15.4)
AMLd (%) 3 (50) 2 (50) 2 (100)
MESTe (%) 1 (16.6) - -
Infectious (%) 2 (33.3) 2 (50) -
aCreatinine.
bGlomerular filtration rate.
cRenal cell carcinoma.
dAngiomyolipoma.
eMixed epidermal stromal tumor.
Table 2: Complications and TRIFECTA
Variables (no. of patients) OPN (26) LPN (14) RAPN (13) P
Postop Complications 2 2 2 --
 Grade 3 1 2 1 --
 Grade 4 1 - 1 --
Total patients with blood transfusion (%) 6 (23) 1(7) 1(7) 0.281
Urine leak/Urinoma 1 2 1 --
Post op proceeded for radical nephrectomy -- 1 -- --
Positive surgical margins 1 1 1 --
Trifecta Achieved (%) 19 (73.1) 9 (64.3) 8 (61.53) 0.730
Not achieved (%) 7 (26.9) 5 (35.7) 5 (38.47)
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which in turn was higher than RAPN. Postoperative days for 
drain removal were significantly lower in RAPN and LPN 
than OPN. WIT was similar in all the three groups. In OPN, 
LPN, and RAPN, postoperative significant complications 
(Clavien grade>2) were 7.6%, 14.2%, and 15.3%, respectively, 
and negative surgical margins were 3.8%, 7.1%, and 7.6%, 
 respectively, but the differences were not significant.
Many studies in the past have compared RAPN with LPN 
and OPN with LPN. Both RAPN and LPN offer equal success 
with low morbidity. Benway et al. in a multi- institutional study 
compared RAPN (129 cases) and LPN (118 cases) (10). Both 
RAPN and LPN had similar postoperative complications in-
cluding urine leak (3 and 4, respectively) and hemorrhage (2 
and 1, respectively). WIT was shorter for RAPN than for LPN 
(19.7 min vs 28.4 min). Similar to our study, blood loss was sig-
nificantly lower in RAPN (155 ml vs 196 ml). Two other single 
institutional studies by Wand et al. and Kural et al. suggested 
no difference in blood loss, complications, and margin status, 
but WIT was lower with RAPN (11, 12). Contradictory to the 
abovementioned studies, Haber et al. compared 75 RAPN with 
75 LPN and noted no significant difference in WIT (18.2 min 
in RAPN vs 20.3 min in LPN) (13). There was significantly 
higher blood loss in RAPN (323  ml) versus LPN (222 ml). 
There was a decrease in postoperative glomerular filtration 
rate (GFR) in 9% patients in both the groups, and 13% RAPN 
and 16% LPN had complications. To summarize, RAPN and 
LPN have same perioperative morbidity in literature. But these 
series do not account for location of tumor or complexity.
Comparison of OPN to RAPN is limited in literature. 
 Several studies have compared OPN to LPN. Gill et al. com-
pared 1,028 OPN with 771 LPN and showed reduced WIT for 
OPN (30.7 min) versus LPN (20.1 min) (14). Similar to our 
study, postoperative complications and positive margins (1.6% 
OPN vs 2.85% LPN) were similar. In contrast to our study, 
blood loss was similar for OPN (300 ml) and LPN (376 ml), 
with 5% blood transfusion rate in both the groups. Further 
the size and configuration of the tumors significantly differed 
as OPN had larger tumors, which were more endophytic.
Pempangkosol et al. compared 58 OPN (median size 2.9 cm) 
with 85 LPN (2.4 cm) (15). In contrast to our study, the overall 
complications were 25% in OPN and 7.8% in LPN. Each group 
had three intraoperative complications, one urine leak/urinoma, 
and two postoperative bleeding that required blood transfusion.
In another study done by Marszalek et al., cases were 
matched by size and configuration (16). They compared 
100 OPN with 100 LPN. They reported shorter median op-
erative time, more frequent intraoperative complications 
(10% vs 3%), and less postoperative complications (14% vs 
19%) in LPN. In our study, OPN and RAPN groups had 
similar median operative time (190 vs 180 min) and WIT 
(23 vs 27 min) while blood loss was less for RAPN than OPN 
(300 ml vs 550 ml). Comparison of WIT is limited because 
cold ischemia time for OPN was not included. Margin status, 
postoperative renal function, and complications were similar.
Lucas et al. did a matched comparison in terms of tumor 
configuration with the help of nephrometry score, tumor size, 
gender, age and compared 54 OPN, 15 LPN, and 27 RAPN 
(17). There was similar distribution of low, medium, and high 
complex lesions in OPN and RAPN while LPN had no high 
complexity lesions. OPN had lower operative time and ischemia 
time but increased blood loss. Postoperatively all groups had 
lower urine leaks (3.7% RAPN, 0 LPN, and 5.6% OPN), with 
similar GFR. Tumor at the specimen margin was also low (3.7% 
RAPN, 0 LPN, and 7.4% OPN). There are some other studies 
comparing Trifecta outcomes in RAPN with LPN (Table 3).
There are limitations to our study. Firstly, the sample size was 
small compared to earlier studies. While we identified statisti-
cally significant differences between different treatment modal-
ities, the study was not adequately powered for detecting subtle 
differences. Secondly, LPN and RAPN cases were not matched 
due to constraints of small cohorts and as the same two surgeons 
performed both LPN and RAPN cases in equal numbers it was 
assumed that LPN cases would be similar to RAPN. Analysis 
reveals that tumors were almost similar in all three groups in all 
aspects. The third limitation is that the surgeries were performed 
by four different surgeons, resulting in differences in total op-
erating time, WIT, and outcomes due to differences in surgical 
technique. A final limitation was that all the RAPN performed 
were the initial robotic surgeries performed at our institution 
and hence the surgeons were in their initial learning curve affect-
ing the total operating time and other outcomes.
Conclusion
Renal tumors can be safely treated by LPN or RAPN with 
lesser morbidity as compared to OPN. Trifecta outcome had 
no significant difference among OPN, LPN, and RAPN. 
Table 3: TRIFECTA in other studies
Studies Year Number
Trifecta  
achieved (%)
Khalifeh et al (18) 2013 500 RAPNa-58 
LPNb-31
Lista et al. (19) 2015 339 RAPN-67
Zargar et al. (20) 2015 1831 RAPN-70 
LPN-33
Carneiro et al. (21) 2015 347 LPN-48 
RAPN-81
Our Study 2018 53 OPNc-73 
LPN-64 
RAPN-62
aRobotic-assisted partial nephrectomy.
bLaparoscopic-assisted partial nephrectomy.
cOpen partial nephrectomy.
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LPN can produce as good results as RAPN. Keeping in mind 
the cost-effectiveness, LPN holds an important position in 
developing countries where expenditure by patient is a major 
factor. It stands equal to open surgeries in terms of surgical 
and oncological outcomes, with significantly lesser morbidity 
than the open procedures.
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